Literature DB >> 12074097

Melatonin protects hepatic mitochondrial respiratory chain activity in senescence-accelerated mice.

Yuji Okatani1, Akihiko Wakatsuki, Russel J Reiter.   

Abstract

Mitochondrial oxidative damage from free radicals may be a factor underlying aging, and melatonin, a powerful free radical scavenger, may participate in mitochondrial metabolism. We measured respiratory chain complex I and IV activities in liver mitochondria from a strain of senescence-accelerated prone mice (SAMP8) and a strain of senescence-accelerated resistant mice (SAMR1) at age 3, 6, and 12 months. No age-associated effects were found in either complex I and IV activities, thiobarbituric acid-reactive substances (TBARS), or glutathione peroxidase (GPx) activity in SAMRI. In contrast, SAMP8 showed significant age-associated decreases in complex I and IV activities. While no age effect was found in TBARS in SAMP8, TBARS levels in SAMP8 were significantly more abundant than in SAMRI. GPx activity in SAMP8 decreased significantly by 12 months. Daily oral melatonin administration (2 microg/mL of drinking fluid) beginning when the mice were 7 months old significantly increased complex I and IV activity, decreased TBARS, and increased GPx activities in both SAMRI and SAMP8 at 12 months. The implication of the findings is that melatonin may be beneficial during aging as it reduced the deteriorative oxidative changes in mitochondria and other portions of the cell associated with advanced age.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074097     DOI: 10.1034/j.1600-079x.2002.1o106.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  13 in total

Review 1.  Melatonin and the electron transport chain.

Authors:  Rüdiger Hardeland
Journal:  Cell Mol Life Sci       Date:  2017-08-07       Impact factor: 9.261

Review 2.  Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance.

Authors:  Rüdiger Hardeland
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 3.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 4.  Neuroprotective Mechanisms of Melatonin in Hemorrhagic Stroke.

Authors:  Hai-Jian Wu; Cheng Wu; Huan-Jiang Niu; Kun Wang; Lian-Jie Mo; An-Wen Shao; Brandon J Dixon; Jian-Min Zhang; Shu-Xu Yang; Yi-Rong Wang
Journal:  Cell Mol Neurobiol       Date:  2017-01-28       Impact factor: 5.046

5.  Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis.

Authors:  Iraj Ragerdi Kashani; Zahra Rajabi; Mohammad Akbari; Gholamreza Hassanzadeh; Alireza Mohseni; Mohammadtaha Kouchakinejad Eramsadati; Kheirollah Rafiee; Cordian Beyer; Markus Kipp; Adib Zendedel
Journal:  Exp Brain Res       Date:  2014-05-06       Impact factor: 1.972

6.  Exogenous Melatonin Ameliorates the Negative Effect of Osmotic Stress in Human and Bovine Ovarian Stromal Cells.

Authors:  Ebrahim Asadi; Atefeh Najafi; James D Benson
Journal:  Antioxidants (Basel)       Date:  2022-05-26

Review 7.  Melatonin regulation of biliary functions.

Authors:  Shannon Glaser; Yuyan Han; Heather Francis; Gianfranco Alpini
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

8.  Melatonin in mitochondrial dysfunction and related disorders.

Authors:  Venkatramanujam Srinivasan; D Warren Spence; Seithikurippu R Pandi-Perumal; Gregory M Brown; Daniel P Cardinali
Journal:  Int J Alzheimers Dis       Date:  2011-05-04

9.  Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug.

Authors:  Rüdiger Hardeland; S R Pandi-Perumal
Journal:  Nutr Metab (Lond)       Date:  2005-09-10       Impact factor: 4.169

10.  Melatonin in Alzheimer's disease and other neurodegenerative disorders.

Authors:  V Srinivasan; S R Pandi-Perumal; D P Cardinali; B Poeggeler; R Hardeland
Journal:  Behav Brain Funct       Date:  2006-05-04       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.